Improving the detection of ATM-associated hereditary cancer is clinically meaningful as it can enable cascade genetic testing for family members who are at risk, facilitate appropriate cancer surveillance for those affected, and prompt the use of precision-based therapies. The gene discussed is ATM; the disease is cancer.